Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Viridian Therapeutics Inc (VRDN)

Viridian Therapeutics Inc (VRDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,063,274
  • Shares Outstanding, K 63,822
  • Annual Sales, $ 310 K
  • Annual Income, $ -237,730 K
  • 60-Month Beta 1.12
  • Price/Sales 3,321.18
  • Price/Cash Flow N/A
  • Price/Book 2.72
Trade VRDN with:

Options Overview Details

View History
  • Implied Volatility 118.89% ( -6.10%)
  • Historical Volatility 60.74%
  • IV Percentile 94%
  • IV Rank 62.85%
  • IV High 172.56% on 06/13/24
  • IV Low 28.08% on 05/22/24
  • Put/Call Vol Ratio 0.03
  • Today's Volume 1,574
  • Volume Avg (30-Day) 376
  • Put/Call OI Ratio 0.59
  • Today's Open Interest 11,576
  • Open Int (30-Day) 8,617

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.87
  • Number of Estimates 8
  • High Estimate -0.80
  • Low Estimate -0.94
  • Prior Year -1.27
  • Growth Rate Est. (year over year) +31.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
11.85 +40.59%
on 07/03/24
17.47 -4.64%
on 07/26/24
+4.35 (+35.34%)
since 06/26/24
3-Month
11.40 +46.14%
on 06/04/24
17.47 -4.64%
on 07/26/24
+3.78 (+29.35%)
since 04/26/24
52-Week
10.93 +52.49%
on 10/25/23
24.18 -31.10%
on 01/09/24
-2.06 (-11.00%)
since 07/26/23

Most Recent Stories

More News
3 Top Small-Cap Tech Picks for Investors This Month

Wall Street believes these three small companies have significant upside potential.

AMZN : 182.50 (+1.47%)
MSFT : 425.27 (+1.64%)
NVDA : 113.06 (+0.69%)
CHPT : 2.19 (+7.88%)
$SPX : 5,459.10 (+1.11%)
VRDN : 16.66 (+1.96%)
SLNO : 48.48 (+3.26%)
2 Growth Stocks Wall Street Analysts Think Can Double in Value

Is now a good time to buy these promising healthcare stocks?

VRDN : 16.66 (+1.96%)
DNA : 0.3702 (+9.98%)
Why Shares of Viridian Therapeutics Are Falling Tuesday

The company announced preliminary trial results for its lead therapy.

HZNP : 116.30 (+0.04%)
VRDN : 16.66 (+1.96%)
Why These 2 Nasdaq Biotech Stocks Fell Hard Tuesday Morning

Broader markets seemed likely to start out on a positive note despite these two outliers.

COMP : 4.44 (+2.78%)
$NASX : 17,357.88 (+1.03%)
VRDN : 16.66 (+1.96%)
IOVA : 9.25 (-1.91%)
Viridian Therapeutics (NASDAQ: VRDN) Shares Positive Clinical Data from Phase 1/2 Trial of VRDN-001 for Treatment of Thyroid Eye Disease

Viridian Therapeutics, Inc. (NASDAQ: VRDN) is engaged as a biotechnology company, which is focused on the research and development of

VRDN : 16.66 (+1.96%)
Bed Bath & Beyond Leads Meme Stocks, But Here's Monday's Big Stock Winner

In a dour market open, here's why these stocks are on the rise.

COMP : 4.44 (+2.78%)
$DOWI : 40,589.34 (+1.64%)
$SPX : 5,459.10 (+1.11%)
$NASX : 17,357.88 (+1.03%)
BBBY : 0.0751 (-27.09%)
VRDN : 16.66 (+1.96%)
Viridian Therapeutics to Report Second Quarter 2022 Financial Results and Host Conference Call on August 15, 2022

WALTHAM, Mass., Aug. 08, 2022 (GLOBE NEWSWIRE) -- Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company advancing new treatments for...

VRDN : 16.66 (+1.96%)
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

WALTHAM, Mass., Aug. 05, 2022 (GLOBE NEWSWIRE) -- Viridian Therapeutics, Inc. (Nasdaq: VRDN) (the “Company” or “Viridian”), a biotechnology company...

VRDN : 16.66 (+1.96%)
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

WALTHAM, Mass., July 08, 2022 (GLOBE NEWSWIRE) -- Viridian Therapeutics, Inc. (Nasdaq: VRDN) (the “Company” or “Viridian”), a biotechnology company...

VRDN : 16.66 (+1.96%)
INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Viridian Therapeutics, Inc. with Losses to Contact the Firm

The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Viridian Therapeutics, Inc. (“Viridian” or “the Company”)...

VRDN : 16.66 (+1.96%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Average short term outlook on maintaining the current direction.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Viridian Therapeutics Inc. is a biotechnology company advancing new treatments for patients suffering from serious diseases. The company's program includes VRDN-001, which is in clinical stage. Viridian Therapeutics Inc., formerly known as miRagen Therapeutics Inc., is based in BOULDER, Colo.

See More

Key Turning Points

3rd Resistance Point 18.62
2nd Resistance Point 18.05
1st Resistance Point 17.35
Last Price 16.66
1st Support Level 16.08
2nd Support Level 15.51
3rd Support Level 14.81

See More

52-Week High 24.18
Fibonacci 61.8% 19.12
Fibonacci 50% 17.55
Last Price 16.66
Fibonacci 38.2% 15.99
52-Week Low 10.93

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar